LA MARCA, SILVIA
LA MARCA, SILVIA
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
A synonymous (c.3390C>T) or a splice-site (c.3380-2A>G) mutation causes exon 26 skipping in four patients with von Willebrand disease (2A/IIE)
2013 M.T. Pagliari, L. Baronciani, I. Garcìa Oya, M. Solimando, S. La Marca, G. Cozzi, F. Stufano, M.T. Canciani, F. Peyvandi
A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen
2013 F. Stufano, A.S. Lawrie, S. La Marca, P.E.C. Berbenni, L. Baronciani, F. Peyvandi
Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies
2019 A. Lecchi, E.A. Femia, S. La Marca, F. Onida, A. Artoni
Alterata morfologia piastrinica nei pazienti con malattia di von Willebrand tipo 2B e 3 : i dati della microscopia elettronica
2007 M. Punzo, S. La Marca, L. Baronciani, A.B. Federici, A. Nurden, P. Nurden
Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study
2021 S. Ghirardello, A. Lecchi, A. Artoni, M. Panigada, S. Aliberti, E. Scalambrino, S. La Marca, M. Boscarino, A. Gramegna, P. Properzi, C. Abruzzese, F. Blasi, G. Grasselli, F. Mosca, A. Tripodi, F. Peyvandi
Complications of whole-exome sequencing for causal gene discovery in primary platelet secretion defects
2019 M.M. Gorski, A. Lecchi, E.A. Femia, S. La Marca, A. Cairo, E. Pappalardo, L.A. Lotta, A. Artoni, F. Peyvandi
Ferric carboxymaltose for sub-acute and chronic iron deficiency anemia in inherited platelet function defects
2020 N. Scaramellini, M. Capecchi, A. Artoni, S. La Marca, M.D. Cappellini, I. Motta
Hemostatic abnormalities in patients with Ehlers–Danlos syndrome
2018 A. Artoni, A. Bassotti, M. Abbattista, B. Marinelli, A. Lecchi, F. Gianniello, M. Clerici, P. Bucciarelli, S. La Marca, F. Payvandi, I. Martinelli
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia
2018 G. Reda, R. Cassin, A. Artoni, B. Fattizzo, A. Lecchi, S. La Marca, P. Bucciarelli, G.V. Levati, F. Peyvandi, A. Cortelezzi
Idelalisib Rapidly Improves Platelets Function in Patients with Chronic Lymphocytic Leukemia (CLL)
2016 G. Reda, R. Cassin, A. Artoni, A. Lecchi, B. Fattizzo, S. LA MARCA, P. Bucciarelli, F. Payvandi, A. Cortelezzi
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia
2021 S. Bonato, A. Artoni, A. Lecchi, G. Schwarz, S. La Marca, L. Padovan, M. Clerici, C. Guadino, G.P. Comi, A. Tripodi, F. Peyvandi
Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels
2015 P. Bucciarelli, S.M. Siboni, F. Stufano, E. Biguzzi, M.T. Canciani, L. Baronciani, M.T. Pagliari, S. La Marca, C. Mistretta, F.R. Rosendaal, F. Peyvandi
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
2023 M. Capecchi, P. De Leo, M. Abbattista, I. Mancini, P. Agosti, M. Biganzoli, C. Suffritti, B. Ferrari, A. Lecchi, S. La Marca, L. Padovan, E. Scalambrino, M. Clerici, A. Tripodi, A. Artoni, R. Gualtierotti, F. Peyvandi